Genmab — August 2020

[DevOp]

Det passer måske meget godt med, at det er lige efter embargo-løft, at der tidligere er sendt pressemeddelelse ud med topline data. Det bliver et spændende efterår og svært at vente til november

[bikube]

Innova T 204 præsenteres oralt på ESMO d. 21. sept. Data fra fase 2.

[StockBull]

Morn https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/86293_Rising_wedge_Aug_27.JPG

[StockBull]

RSI ser fornuftig ud om mon ikke den positive trend fortsætter. Der kom 2 nye signaler igår som er vedhæftet. Spændende op vi skal op over 2500 kommende uger. Såfremt vi bliver i kanalen kan kurs 2500 være brudt inden 22 September

[StockBull]

Just a moment...

(www.proinvestor.com)

[Helge_LarsenPI-redaktør]

God morgen.

[bibob]

God morgen.

[transalp]

Go morgen..

[Helge_LarsenPI-redaktør]

Transcript: https://www.proinvestor.com/index.php?p=debat_1&postid=86295

[Darvin]

M.h.t. TV 204 på ESMO, så gjorde han en del ud af dette på Q&A I går, bl.a.: "We very much look forward to discussing these results with the FDA and the potential for the first BLA submission for one of our proprietary therapeutic candidates, which would be an important milestone in our company’s history.."

[Helge_LarsenPI-redaktør]

Genmab News - Phase 2 innovaTV 204 study results accepted as a late-breaking abstract at the ESMO Virtual Congress, 2020. Oral presentation is at 17:04 CEST on Sep 21, 2020.
http://ow.ly/gdxj50Ba5F7

[Darvin]

Så 21 sept får vi formentligt lidt mere at tygge på

[DevOp]

abstract fra oral pres. frigives d.19. sept og de har desuden en poster pres. allerede d.17.

[KWC]

Handelsbanken skruer op for Genmab-kursmål
Handelsbanken løfter kursmålet for aktien i Genmab til 1920 kr. fra 1760 kr. og gentager den neutrale anbefaling "hold". Well....

[E_L]

i am wondering if it is the first late-breaking abstract by Genmab for a major congress, where they are developing the drug themselves? Ofa and Dara were probably already out-licenced?

[w]

if 1920, why not a sel
l recommendation?

[w]

sell

[E_L]

because they already know they will have to upgrade it again next month, and the month after, and....

[E_L]

Finally an update on Epcoritamab in clinicaltrials https://www.clinicaltrials.gov/ct2/history/NCT03625037?A=9&B=10&C=merged#StudyPageTop - large change in Anticipated Enrollment: (from 110 to 386) and participating locations

[Bulder]

Thx E L. Looks awesome.